| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |